Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study

SIMPLE SUMMARY: Cemiplimab is used in the treatment of advanced cutaneous squamous cell carcinoma. Synergistic antitumoral response by concurrent radiotherapy and immunotherapy seems promising. We collected data from patients who were administered cemiplimab in Caen Hospital. Our primary objective w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly-Caillé, Barbara, Kottler, Diane, Morello, Rémy, Lecornu, Marie, Kao, William, Meyer, Emmanuel, Dompmartin, Anne, L’Orphelin, Jean-Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856754/
https://www.ncbi.nlm.nih.gov/pubmed/36672444
http://dx.doi.org/10.3390/cancers15020495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856754/
https://www.ncbi.nlm.nih.gov/pubmed/36672444
http://dx.doi.org/10.3390/cancers15020495

Ejemplares similares